[Case conferences: sudden death of the mother during delivery and problems concerning obstetrical emergencies].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E Matsuo.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A series of pilot studies are presented utilizing mouse and human infections with M. leprae and mouse infections with M. lepraemurium relating to the previously reported finding that hyaluronic acid seems to be a major nutrient substrate for these bacilli. The "feeding" of hyaluronic acid to the bacilli enhanced the growth of M. leprae in mouse abdominal walls and increased the Morphologic Index of M. lepraemurium infection. Saccharic acid, an inhibitor of beta-glucuronidase previously reported as present in these leprosy bacilli, caused marked regression of advanced M. lepraemurium infection, inhii. Ascorbic acid (vitamin C), also an inhibitor of beta-glucuronidase, given at a level of 1.5 gm/day for 4.5 months to one lepromatous patient without other treatment and for up to 24 months to four other lepromatous patients receiving DDS, was accompanied by lesion regression and changes in bacillary morphology similar to those seen in the inhibitor treated mice. If these observations are confirmed the possible use of beta-glucuronidase inhibitors as a useful adjunct to other leprosy therapy is raised as is also the likelihood of developing new therapies.
A histochemical analysis of 102 skin biopsies from a variety of leprosy types revealed the persistent presence of hyaluronic acid in lepra cells of lepromas. In contrast, the hyaluronic acid content of tuberculoid epithelioid cells showed a minimum amount of hyaluronic acid and hyaluronic acid tended to disappear from these granulomas as they aged. The macrophages of dimorphous leprosy occupied an intermediate position with respect to hyaluronic acid content and distribution, resembling the tuberculoid in BT cases and the lepromatous expression in BL cases. It is suggested that hyaluronic acid, in a manner similar to M. leprae and lipid, has a quantitatively varied distribution reflecting the immunopathologic spectrum of leprosy. This finding suggests that acid mucopolysaccharide may be significantly involved in that host/parasite interaction in leprosy.
Electron- and light microscopic analyses were conducted on leprosy skin biopsies relative to the origin of hyaluronic acid, which has previously been observed to be distributed inversely in ratio to the degree of cell- mediated immunity. The present study investigated the subcellular localization of hyaluronic acid and its degrading enzyme in various types of leprosy. Hyaluronic acid in some lepromatous leprosy cases was shown to be accumulated in the limiting membranes of the phagosomes of lepra cells and Myco-bacteria leprae have beta-glucuronidase which plays a role in the degradation of hyaluronic acid. Contrariwise, in tuberculoid leprosy, beta-glucuronidase was detected in the lysosomes of epithelioid cells and giant cells. This result suggests that the origin of hyaluronic acid is in histiocytes and at the same time it might suggest that M. leprae is in competition with enzymes of epithelioid cells for hyaluronic acid, whereas reduced or absent beta-glucuronidase in lepra cells enable bacilli to utilize the AMPS as a nutrient.
The reportedly unique pyridine extractability of acid-fastness as an identifying characteristic for M. leprae was examined in the leprosy bacilli and in eight other strains of mycobacteria. The initial findings were, in general, in accord with previous reports except that M. smegmatis and M. phlei likewise demonstrated two hour pyridine extractability of acid-fastness. Perhaps, more significantly, it was found that this characteristic in M. leprae is related to aged, probably nonviable bacilli. Some other strains of mycobacteria when tested in aged cultures showed the same phenomenon while M. leprae cultivated in vitro in a recently developed medium resisted pyridine extraction up to three weeks of growth, but thereafter as the culture aged pyridine extractability became characteristic. It is concluded that this pyridine extractability of acid-fastness is a characteristic of aging or nonviable bacilli. As such it is not definitive in the determination of whether or not in vitro cultivation of M. leprae has been achieved.
A markedly improved immunofluorescent technic employing FITC conjugated IgG antibody prepared from lepromatous serum is described as a means of specific identification of M. leprae. An additional immunologic identification method for M. leprae is presented as a micro-complement fixation technic employing antigen rather than antibody dilution. Studies with these technics suggest that M. leprae specific antigen is probably a surface antigen and has as part of its mosaic a lecithin-phospholipid component. It is not unlikely that it is a protein-glyco-phospholipid with a polysaccharide component. These technics employed with nodular extract (NE) from lepromas, with 15 strains of mycobacteria, with M. leprae from human tissue as well as from previously reported in vitro culture, strongly reinforce the allegation that M. leprae is readily cultivated in vitro in the hyaluronic acid based medium LA-3, previously reported.
In vitro cultivation is reported of Mycobacterium leprae on a medium (designated LA-3) based on hyaluronic acid with additional ingredients of yeast extract, bovine albumin and glycerin together with phosphate buffer. The medium is also incorporated with agar or agarose (designated LA-3P) to serve as culture plates. Initial growth in LA-3 in test tubes required about six weeks but subsequently this was speeded up to about two weeks utilizing large quantities of media with aeration by shaking twice a day. Growth on LA-3P yields numerous small orange-yellow colonies in two to three weeks. Facets of the emerging aspects of the life cycle of M. leprae under cultivation are given preliminary report. The bases for the allegation of M. leprae identity of the cultured bacilli are essentially the following six determinations. 1. Pathologic and experimental determined rationale for the essential M. leprae nutrient requirement. 2. Several cultures having the same characteristics have been isolated from LL patients widely separate in time and by geography. 3. Failure of culture isolates to subculture on the usual media employed in the cultivation of mycobacteria at both 37 degrees C and room temperature. 4. 1 degree cultures in liquid medium successfully transferred to 2 degrees liquid medium and to 2 degrees agar medium plates. 5. Bacillary isolates and bacilli of 1 degree and 2 degrees liquid medium cultures all stain with pooled LL serum, FITC coupled, M. leprae specific antibody with which a broad range of other mycobacteria do not react. 6. M. lepraemurium also presents good growth on this medium.
In vitro cultivation of M. leprae requires a rapid, specific identification procedure for monitoring the cultures. A method utilizing direct FITC-coupled lepromatous, specific serum globulin is described in detail with suggestions for improvement. After various purification and adsorption procedures, notably against human liver powder and M. tuberculosis, a fluorescent serum preparation is obtained which specifically reacts with M. leprae and not with other mycobacteria.
Explore the source record for details and available documents.